Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra. 👉 Read more: bit.ly/46xigrJ

MMV & partners, with support from Global Health Innovative Technology (GHIT) Fund, have launched a Phase 3 trial of a novel triple therapy (TACT) – the first for uncomplicated #malaria – to help tackle drug resistance & protect the efficacy of existing medicines. 👉 bit.ly/4guQL6L

A single dose, a stronger #malaria elimination strategy. 👏Congrats to Peru for adopting single-dose tafenoquine + point-of-care G6PD testing to fight relapsing malaria – a milestone made possible through strong research partnerships 👉 bit.ly/3K9GWzj

Are the mosquitoes that transmit #malaria changing with fluctuating climate conditions? A new @itmantwerp.bsky.social study shows warmer, variable conditions can “reprogram” mosquito biology, making them more resilient & altering transmission patterns 👉 bit.ly/46xVmBH

In @telegraphnews.bsky.social, Dr Ibrahima Socé Fall argues that tackling #malaria, #dengue & #TB is key to saving lives today and preparing for future outbreaks of pandemic potential. 👉 bit.ly/3I4hcU0

For the 4th year in a row, MMV is a ‘very high performer’ in the Global Health 50/50 report. Gender equity drives better science, stronger partnerships and impact in #malaria elimination, and it’s essential to global health security. Learn more 👉 bit.ly/4glIWAb

📢 The Big Push Against Malaria is accelerating global progress towards eradication. On the sidelines, the SMC Alliance — including MMV — is reaffirming the crucial role of seasonal #malaria chemoprevention in protecting children during peak seasons 👉 bit.ly/4ngUhUr

Each addition to the #malaria prevention toolbox advances the elimination agenda. Last month, @who.int recommended spatial emanators, the 1st new vector control product in +40 years. Here's how spatial emanators can help prevent deadly mosquito bites: bit.ly/4njHRLQ

Partial resistance to artemisinin threatens #malaria treatments (ACTs) and risks undoing decades of progress. A new @thelancetinfdis.bsky.social study shows how diversifying ACT use in endemic countries could protect efficacy & buy time for next-gen drugs. 👉 bit.ly/41yFRH1

This Wednesday, @path.org will host a webinar on expanding the impact of #malaria chemoprevention. Join to learn about implementation experiences & how to deliver these prevention tools more widely & equitably. Register here 👉 bit.ly/3UZRDXa

Africa is facing a perfect storm against #malaria, including drug resistance, critical funding gaps & climate change. At #RC75, Ministers of Health, partners & global health leaders issued an urgent call to accelerate malaria prevention & control: bit.ly/45YEqmv

#TICAD9 concluded with the Yokohama Declaration, reinforcing Japan-Africa collaboration for development & stability. Civil society advocates have responded with a statement supporting stronger health security & sustainable development in Africa: bit.ly/46ouEun

The authorization of the first-ever #malaria treatment for newborns & young infants represents a major step towards closing a decades-long gap in paediatric malaria care. But why did it take so long to achieve this milestone? @scidevnet.bsky.social investigates: bit.ly/47Y94Px

The 6th PAVE LATAM meeting in Lima gathered partners to align science & policy for relapsing vivax #malaria elimination. From new treatments to cross-border collaboration, momentum is growing. MMV is proud to co-lead this effort with @path.org. Stay tuned for highlights!

Behind every breakthrough is a dedicated face in the lab Meet the scientists & technicians @lshtm.bsky.social & @mrcunitgambia.bsky.social working to understand 🦟 & fight malaria, dengue, Zika, & more. This #WorldMosquitoDay2025, let’s shine a light on their vital work. 👉 bit.ly/45qtn6F

With 14,000 mosquitoes for every human on the planet, we need to level the playing field in the fight against diseases they spread. PDPs like MMV & @dndi.org work across the global health community to deliver new tools & ensure access where they’re needed most. #WorldMosquitoDay

🚀 Imagine a world where #malaria is a thing of the past. With next-gen medicines, innovative #vaccines & smart vector control combined, we’ll be one step closer. Join us this #WorldMosquitoDay in combating malaria, a disease spread by the world’s most dangerous animal.

Recent studies are exploring how genetic tools can interrupt #malaria transmission at different biological stages – from modifying mosquitoes to block parasite development, to reducing their ability to pass it on. Learn more about this research: bit.ly/4olRomL

💊 Resistance to life-saving #malaria medicines threatens 2 decades of progress against the disease. In response, MMV and partners are accelerating #innovation, development and access to next-generation antimalarials with high barriers to resistance: bit.ly/3Zso5ow

Malaria doesn’t have to be deadly to be devastating. In young children, even asymptomatic infections can derail growth. A new study from Malawi links asymptomatic #malaria to poorer nutrition & development in infants. Read more in @springer.springernature.com: bit.ly/3UdYewM

Heading to #TICAD9? MMV, Nagasaki University & Shionogi Inc. are hosting a side event next Friday to explore the relationship between global health & economic development, & Japan's role in building a healthier, more prosperous world for all. 👉 Register: bit.ly/4muX3oO

Kenya's MoH, @malarianomore.org & the Kenya Medical Research Institute will monitor antimalarial drug resistance & study the effectiveness of mosquito ceiling nets to inform policy & prevention initiatives in the country, where 70% of the population is at risk of #malaria: bit.ly/4fmm1o1

On the International Day of the World’s Indigenous Peoples, we’re highlighting the importance of equitable access to care in countries like Brazil, where #malaria elimination depends on ensuring that Indigenous populations are not left behind 🎥 bit.ly/4fxQhfN

How can we build resilience amid the threats #ClimateChange poses to #malaria elimination? Key strategies, best practices & innovative tools discussed during a #WHA side event organized by MMV & partners have been consolidated in a detailed report: bit.ly/3IOeQJ6

Malaria is both a cause & consequence of poverty, slowing economic growth & trapping the people it infects in cycles of poverty. Yet, defeating #malaria by 2030 remains one of the highest-impact investments we can make in global health 👉 bit.ly/4iluecm

According to the Society for Family Health (SFH) Nigeria, #malaria kills 9 people every hour in the country. The NGO’s latest prevention campaign is taking an integrated approach, distributing 7.7M ITNs & +15M doses of SMC to children 5 and under. Read more in the Guardian Nigeria: bit.ly/4l6w0iC

📢 Calling all African scientists. Do you have an idea that can help accelerate #malaria drug discovery? MMV’s 8th African call for proposals is still open, so make sure to submit your application by 29 August 2025. Learn more: bit.ly/4dLbSk7

🦟 Vector surveillance is vital for #malaria control but it takes practical skill & know-how. Join APMEN & @malariaconsortium.bsky.social for a free online workshop led by Prof. Neil Lobo on strengthening vector control strategies. 📅 5–7 Aug 🔗 Register: bit.ly/45fGEh5

📢 MMV & APMEN’s Vivax Working Group recently hosted a side meeting at #APLMA2025 in Bali, with leaders from 🇵🇰 🇳🇵 🇰🇷 🇸🇧 sharing insights and strategies on accelerating access to radical cure tools for relapsing vivax #malaria. Read more: bit.ly/45mymVI

🇧🇷 Brazil has incorporated a child-friendly formulation of tafenoquine into its public health system, taking an important step towards protecting children from P. vivax #malaria, the dominant form of the disease in Latin America. Learn more: bit.ly/4fgk4JS

New #malaria outbreaks have been reported in southern #Africa. This resurgence underscores the urgent need for: ✅ Continued investment ✅ Regional cooperation ✅ Cross-border surveillance ✅ Timely & accurate data collection Read more: bit.ly/46wxe38

🎉 Congratulations to Timor-Leste for being certified malaria-free by @who.int. From a peak of over 223,000 #malaria cases in 2006 to zero indigenous cases since 2021, this achievement reflects a tremendous public health effort. Read more: bit.ly/4miKa0Z

💻 In case you missed it: MMV researchers recently took part in a webinar hosted by Collaborative Drug Discovery to discuss breakthrough approaches to combating #malaria drug resistance and accelerating antimalarial development. Check it out here: bit.ly/46OSEII

Pregnancy puts women at greater risk of severe #malaria infection, affecting both mother & baby. Treatment options for pregnant women are limited, especially in the 1st trimester, but the SAFIRE consortium is working to change this. Learn more: bit.ly/44brM3O

This week's global news press releases include: - @who.int recommend lenacapavir - @unaids.org respond - ViiV Healthcare long-acting HIV medication - @mmv.org $1 malaria prevention - UK healthcare onboarding RSV vaccines for vulnerable babies. Read more: www.liverpool.ac.uk/centre-of-ex...

A new publication underscores the urgent need to diversify the global antimalarial drug portfolio with novel interventions & examines how MMV’s portfolio of non-artemisinin-based compounds currently in development is addressing this need: bit.ly/3GUJjVe

New research published in Science Magazine finds that tropical cyclones lead to sharp spikes in #malaria infections & reinfections, especially among children. Learn why we need to strengthen malaria control in climate-vulnerable regions: bit.ly/4kKSLbt

MMV and Eyam Health are partnering to develop next-gen monoclonal antibody-based #malaria therapies. The goal? Harnessing advanced biologics and AI to deliver a long-lasting malaria prevention shot that could cost less than $1 per dose. Press release: bit.ly/3ID3gjT

MMV, @LPIXEL_Inc & @dundeeuni are partnering to accelerate #malaria drug discovery using advanced AI-powered image analysis. This partnership aims to develop a platform that could shave months off the process of screening & selecting compounds. Learn more: bit.ly/44Roq5o

Explore our digital annual report for a snapshot of MMV’s 2024 achievements, insights into how our partnerships are advancing the #malaria elimination agenda & stories about our impact on individuals & communities. MMV’s new report is live here: bit.ly/3U0da1D

In 2024, an average of 565,702 children received SMC in Togo to protect them from #malaria during the period of the year when transmission is at its highest. Together with other preventive interventions, SMC is key to achieving the dream of a malaria-free future.

📢 Press release: The antimalarial toolbox just expanded, bringing hope to the smallest patients. The first #malaria treatment for newborns and young infants has been approved by @swissmedic.bsky.social, with fast-track approvals expected across Africa.

Congrats to Suriname, the first country in the Amazon region to earn WHO malaria-free certification! From the highest #malaria rates in the Americas in 2001 to zero today. A testament to strong commitment & collaboration. Learn more: bit.ly/4ntxlCo

MMV’s 8th African call for proposals runs until 29 August 🧬 bit.ly/4dLbSk7 Curious to know what it’s like to be part of this initiative advancing innovative R&D across Africa? Cláudia Fançony shares her experience & journey with MMV: bit.ly/4njO5My

🦟 Drug resistance threatens global #malaria control. One promising strategy: multiple first-line therapies (MFT) – using different treatments simultaneously to slow resistance. 🤝 MMV is supporting MFT pilots in Ghana, Cameroon & Tanzania 🔗 bit.ly/40gbfcs

MMV recently presented the Kenya-based pharma company Universal Corporation Ltd. with a special award 🏆 to honour its leadership in advancing African manufacturing and its impactful collaboration with MMV in the fight against #malaria 🔗 Read more: bit.ly/4kW61ev

🎓After completing their internships at the Parasites & Microbes Research & Training Center, the second cohort of Ogobara K. Doumbo Scholarship Fund recipients shared how this opportunity has shaped their early careers 🧪 and inspired their commitment to the fight against #malaria 👉 bit.ly/40aWzLO

A collaboration between APMEN VxWG + 13 Asia Pacific NMPs evaluates the Options Assessment Toolkit, designed to support P. vivax #malaria elimination strategies. Regional collaboration is key to elimination 🤝 📖 Read: bit.ly/4ndpfh9

🎥 Set in Lupweshi village in the Democratic Republic of Congo, this film documents Chatie Kalukwa Kalobo’s journey to save her son from severe #malaria and shows how community health workers can make a difference. Watch the full film: bit.ly/44iajWa

An incredible week at #EDCTPForum in Kigali! We connected face-to-face with partners, shared updates from EDCTP consortia we’re part of, and embraced the challenge of going faster and farther together for global health.